Amgen has announced it is developing its already marketed psoriasis drug Otezla as a potential treatment for COVID-19, the respiratory disease caused by the SARS-CoV-2 coronavirus. Otezla ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback